Monocytes in sterile inflammation: Recruitment and functional consequences

Archivum Immunologiae et Therapiae Experimentalis

Volumn 62, Issue 3, 2014, Pages 187-194

  Spahn, Jessica H ^a   Kreisel, Daniel ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Functional outcome; Monocytes; Recruitment; Sterile inflammation

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; COLLAGENASE 3; CXCL2 CHEMOKINE; FRACTALKINE; GELATINASE B; GLYCOPROTEIN P 15095; HEAT SHOCK PROTEIN 70; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ASPERGILLUS FUMIGATUS; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLASSICAL MONOCYTE; DENDRITIC CELL; ENDOTHELIUM CELL; HEART INFARCTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LEGIONELLA PNEUMOPHILA; LISTERIA MONOCYTOGENES; MACROPHAGE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONCLASSICAL MONOCYTE; NONHUMAN; PANCREAS CANCER; PHAGOCYTE; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SALMONELLA TYPHIMURIUM; SPINAL CORD INJURY; TOXOPLASMA GONDII; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; CELL MOTION; DISEASE MODEL; IMMUNOLOGY; INJURY; INNATE IMMUNITY; MOUSE;

ANIMALS; ATHEROSCLEROSIS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MICE; MONOCYTES; REPERFUSION INJURY; WOUNDS AND INJURIES;

EID: 84901641838     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-013-0267-5     Document Type: Review

References (56)

1. Armstrong DA, Major JA, Chudyk A et al (2004) Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury. J Leukoc Biol 75:641-648 (Pubitemid 38405655)
2. Arnold L, Henry A, Poron F et al (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204:1057-1069 (Pubitemid 46798150)
3. Auffray C, Fogg D, Garfa M et al (2007) Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317:666-670 (Pubitemid 47229966)
4. Bamboat ZM, Ocuin LM, Balachandran VP et al (2010) Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J Clin Invest 120:559-569
5. Belperio JA, Keane MP, Burdick MD et al (2001) Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J Clin Invest 108:547-556 (Pubitemid 32777734)
6. Boring L, Gosling J, Cleary M et al (1998) Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894-897 (Pubitemid 28410911)
7. Chen GY, Nunez G (2010) Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10:826-837
8. Dimitrijevic OB, Stamatovic SM, Keep RF et al (2006) Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J Cereb Blood Flow Metab 26:797-810
9. Dimitrijevic OB, Stamatovic SM, Keep RF et al (2007) Absence of the chemokine receptor CCR2 protects against cerebral ischemia/ reperfusion injury in mice. Stroke 38:1345-1353 (Pubitemid 351664259)
10. Fong AM, Erickson HP, Zachariah JP et al (2000) Ultrastructure and function of the fractalkine mucin domain in CX(3)C chemokine domain presentation. J Biol Chem 275:3781-3786 (Pubitemid 30094599)
11. Furuichi K, Gao JL, Murphy PM (2006) Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemiareperfusion injury. Am J Pathol 169:372-387 (Pubitemid 44156300)
12. Geissmann F, Jung S, Littman DR (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71-82 (Pubitemid 36859902)
13. Gelman AE, Okazaki M, Sugimoto S et al (2010) CCR2 regulates monocyte recruitment as well as CD4 T1 allorecognition after lung transplantation. Am J Transplant 10:1189-1199
14. Gerszten RE, Garcia-Zepeda EA, Lim YC et al (1999) MCP-1 and IL- 8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398:718-723
15. Grau V, Stehling O, Garn H et al (2001) Accumulating monocytes in the vasculature of rat renal allografts: phenotype, cytokine, inducible no synthase, and tissue factor mRNA expression. Transplantation 71:37-46 (Pubitemid 32105776)
16. Hecker A, Mikulski Z, Lips KS et al (2009) Pivotal advance: upregulation of acetylcholine synthesis and paracrine cholinergic signaling in intravascular transplant leukocytes during rejection of rat renal allografts. J Leukoc Biol 86:13-22
17. Ingersoll MA, Platt AM, Potteaux S et al (2011) Monocyte trafficking in acute and chronic inflammation. Trends Immunol 32:470-477
18. Jacquelin S, Licata F, Dorgham K et al (2013) CX3CR1 reduces Ly6Chigh-monocyte motility within, and release from the bone marrow after chemotherapy in mice. Blood 122:674-683
19. Johnson CH, Miao C, Blanchard EG et al (2012) Effect of chemokine receptor CX3CR1 deficiency in a murine model of respiratory syncytial virus infection. Comp Med 62:14-20
20. Kikuchi T, Andarini S, Xin H et al (2005) Involvement of fractalkine/ CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila . Infect Immun 73:5350-5357 (Pubitemid 41192968)
21. Kreisel D, Nava RG, Li W et al (2010) In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation. Proc Natl Acad Sci USA 107:18073-18078
22. Landsman L, Jung S (2007) Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J Immunol 179:3488-3494
23. Leuschner F, Rauch PJ, Ueno T et al (2012) Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med 209:123-137
24. Louvet C, Heslan JM, Merieau E et al (2004) Induction of fractalkine and CX3CR1 mediated by host CD8? T cells in allograft tolerance induced by donor specific blood transfusion. Transplantation 78:1259-1266 (Pubitemid 39507962)
25. Lu H, Huang D, Ransohoff RM et al (2011) Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J 25:3344-3355
26. Martinez CO, McHale MJ, Wells JT et al (2010) Regulation of skeletal muscle regeneration by CCR2-activating chemokines is directly related to macrophage recruitment. Am J Physiol Regul Integr Comp Physiol 299:R832-R842
27. Maus U, Henning S, Wenschuh H et al (2002) Role of endothelial MCP-1 in monocyte adhesion to inflamed human endothelium under physiological flow. Am J Physiol Heart Circ Physiol 283:H2584-H2591 (Pubitemid 35345966)
28. Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1:135-145
29. Metinko AP, Kunkel SL, Standiford TJ et al (1992) Anoxia- hyperoxia induces monocyte-derived interleukin-8. J Clin Invest 90:791-798
30. Nahrendorf M, Swirski FK, Aikawa E et al (2007) The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 204:3037-3047 (Pubitemid 350179569)
31. Niess JH, Brand S, Gu X et al (2005) CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307:254-258 (Pubitemid 40116240)
32. Oh DJ, Dursun B, He Z et al (2008) Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am J Physiol Renal Physiol 294:F264-F271
33. Padi SS, Shi XQ, Zhao YQ et al (2012) Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation. Pain 153:95-106
34. Robinson LA, Nataraj C, Thomas DW et al (2000) A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 165:6067-6072
35. Ryu J, Lee CW, Hong KH et al (2008) Activation of fractalkine/ CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Cardiovasc Res 78:333-340 (Pubitemid 351556089)
36. Sanford DE, Belt BA, Panni RZ et al (2013) Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis. Clin Cancer Res 19:3404-3415
37. Satoh M, Shimoda Y, Akatsu T et al (2006) Elevated circulating levels of heat shock protein 70 are related to systemic inflammatory reaction through monocyte Toll signal in patients with heart failure after acute myocardial infarction. Eur J Heart Fail 8:810-815 (Pubitemid 44779418)
38. Sayyed SG, Ryu M, Kulkarni OP et al (2011) An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. Kidney Int 80:68-78
39. Serbina NV, Pamer EG (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7:311-317
40. Serbina NV, Jia T, Hohl TM et al (2008) Monocyte-mediated defense against microbial pathogens. Ann Rev Immunol 26:421-452 (Pubitemid 351600381)
41. Shechter R, London A, Varol C et al (2009) Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 6:e1000113
42. Shechter R, Raposo C, London A et al (2011) The glial scarmonocyte interplay: a pivotal resolution phase in spinal cord repair. PLoS ONE 6:e27969
43. Shi C, Pamer EG (2011) Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11:762-774
44. Soriano SG, Amaravadi LS, Wang YF et al (2002) Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol 125:59-65 (Pubitemid 34327454)
45. Sunderkotter C, Nikolic T, Dillon MJ et al (2004) Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 172:4410-4417 (Pubitemid 38375256)
46. Swirski FK, Nahrendorf M, Etzrodt M et al (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325:612-616
47. Szmydynger-Chodobska J, Strazielle N, Gandy JR et al (2012) Posttraumatic invasion of monocytes across the blood-cerebrospinal fluid barrier. J Cereb Blood Flow Metab 32:93-104
48. Tacke F, Alvarez D, Kaplan TJ et al (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117:185-194 (Pubitemid 46048465)
49. Tsan MF, Gao B (2004) Endogenous ligands of Toll-like receptors. J Leukoc Biol 76:514-519
50. Tsou CL, Peters W, Si Y et al (2007) Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 117:902-909 (Pubitemid 46556746)
51. Warren GL, O'Farrell L, Summan M et al (2004) Role of CC chemokines in skeletal muscle functional restoration after injury. Am J Physiol Cell Physiol 286:C1031-C1036 (Pubitemid 38506918)
52. Warren GL, Hulderman T, Mishra D et al (2005) Chemokine receptor CCR2 involvement in skeletal muscle regeneration. FASEB J 19:413-415 (Pubitemid 40316534)
53. Xue CB, Wang A, Meloni D et al (2010) Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2. Bioorg Med Chem Lett 20:7473-7478
54. Zakrzewicz A, Krasteva G, Wilhelm J et al (2011) Reduced expression of arrestin beta 2 by graft monocytes during acute rejection of rat kidneys. Immunobiology 216:854-861
55. Zhang H, Trivedi A, Lee JU et al (2011) Matrix metalloproteinase-9 and stromal cell-derived factor-1 act synergistically to support migration of blood-borne monocytes into the injured spinal cord. J Neurosci 31:15894-15903
56. Ziegler-Heitbrock L, Ancuta P, Crowe S et al (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116:e74-e80